Literature DB >> 10339464

The apoptosis inhibitor gene API2 and a novel 18q gene, MLT, are recurrently rearranged in the t(11;18)(q21;q21) associated with mucosa-associated lymphoid tissue lymphomas.

J Dierlamm1, M Baens, I Wlodarska, M Stefanova-Ouzounova, J M Hernandez, D K Hossfeld, C De Wolf-Peeters, A Hagemeijer, H Van den Berghe, P Marynen.   

Abstract

Marginal zone cell lymphomas of the mucosa-associated lymphoid tissue (MALT) are the most common subtype of lymphoma arising at extranodal sites. The t(11;18)(q21;q21) appears to be the key genetic lesion and is found in approximately 50% of cytogenetically abnormal low-grade MALT lymphomas. We show that the API2 gene, encoding an inhibitor of apoptosis also known as c-IAP2, HIAP1, and MIHC, and a novel gene on 18q21 characterized by several Ig-like C2-type domains, named MLT, are recurrently rearranged in the t(11;18). In both MALT lymphomas analyzed, the breakpoint in API2 occurred in the intron separating the exons coding respectively for the baculovirus IAP repeat domains and the caspase recruitment domain. The breakpoints within MLT differed but the open reading frame was conserved in both cases. In one case, the translocation was accompanied by a cryptic deletion involving the 3' part of API2. As a result, the reciprocal transcript was not present, strongly suggesting that the API2-MLT fusion is involved in the oncogenesis of MALT lymphoma.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10339464

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  135 in total

1.  The product of the t(11;18), an API2-MLT fusion, marks nearly half of gastric MALT type lymphomas without large cell proliferation.

Authors:  M Baens; B Maes; A Steyls; K Geboes; P Marynen; C De Wolf-Peeters
Journal:  Am J Pathol       Date:  2000-04       Impact factor: 4.307

Review 2.  Molecular diagnostic approach to non-Hodgkin's lymphoma.

Authors:  D A Arber
Journal:  J Mol Diagn       Date:  2000-11       Impact factor: 5.568

3.  Predicting protein cellular localization using a domain projection method.

Authors:  Richard Mott; Jörg Schultz; Peer Bork; Chris P Ponting
Journal:  Genome Res       Date:  2002-08       Impact factor: 9.043

Review 4.  Oncogenic activation of NF-kappaB.

Authors:  Louis M Staudt
Journal:  Cold Spring Harb Perspect Biol       Date:  2010-04-21       Impact factor: 10.005

5.  Mechanism and specificity of the human paracaspase MALT1.

Authors:  Janna Hachmann; Scott J Snipas; Bram J van Raam; Erik M Cancino; Emily J Houlihan; Marcin Poreba; Paulina Kasperkiewicz; Marcin Drag; Guy S Salvesen
Journal:  Biochem J       Date:  2012-04-01       Impact factor: 3.857

Review 6.  30 Years of NF-κB: A Blossoming of Relevance to Human Pathobiology.

Authors:  Qian Zhang; Michael J Lenardo; David Baltimore
Journal:  Cell       Date:  2017-01-12       Impact factor: 41.582

7.  Exclusive detection of the t(11;18)(q21;q21) in extranodal marginal zone B cell lymphomas (MZBL) of MALT type in contrast to other MZBL and extranodal large B cell lymphomas.

Authors:  A Rosenwald; G Ott; S Stilgenbauer; J Kalla; M Bredt; T Katzenberger; A Greiner; M M Ott; B Gawin; H Döhner; H K Müller-Hermelink
Journal:  Am J Pathol       Date:  1999-12       Impact factor: 4.307

Review 8.  The Paracaspase MALT1.

Authors:  Janna Hachmann; Guy S Salvesen
Journal:  Biochimie       Date:  2015-09-16       Impact factor: 4.079

9.  Detection of API2-MALT1 fusion transcripts in cytologic specimens of patients with pulmonary mucosa-associated lymphoid tissue lymphoma.

Authors:  Hiroshi Inagaki; Chunmei Li; Mitsukuni Okabe; Mitsunori Nishikawa; A Mitsunori Nishikawa; Shinsuke Iida; Ryuzo Ueda
Journal:  Int J Hematol       Date:  2005-07       Impact factor: 2.490

Review 10.  CARMA1-mediated NF-kappaB and JNK activation in lymphocytes.

Authors:  Marzenna Blonska; Xin Lin
Journal:  Immunol Rev       Date:  2009-03       Impact factor: 12.988

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.